Newsletter
SEMPRE: Partnerships for Better Outcomes with Kati Sadiwnyk, Head of Lantus and Biosimilars at Sanofi

Outcomes Rocket

SEMPRE: Partnerships for Better Outcomes with Kati Sadiwnyk, Head of Lantus and Biosimilars at Sanofi

December 28, 2022

SEMPRE: Partnerships for Better Outcomes with Kati Sadiwnyk, Head of Lantus and Biosimilars at Sanofi

Working together towards health equity.

In this episode, Kyle talks with Kati Sadiwnyk, Head of Lantus and Biosimilars at Sanofi, about how she’s advocating for patients and what the partnership with DarioHealth seeks to bring. She explains some of the advocacy programs that Sanofi is working on, focusing on insulin affordability and behavioral modification. Finally, Kati shares her thoughts on value-based contracts and a personal anecdote that made her see the value of being a vulnerable leader.

Listen to what Kati says about patient advocacy and Sanofi’s work to improve health equity!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Nashville’s Opportunity: Eco-Action or Anxiety In this excerpt from a Climate x Health Twitter Spaces live chat, experts from Vanderbilt, Oak Ridge National Laboratory, and others discuss hope and want listeners to be energetic and reject “doomerism” while embracing reality and emphasizing teamwork without ego to accomplish individual and systemic goals. This conversation was hosted live from the AAMC conference in Nashville.